Darius Kharabi is a co-founder of Lagunita and is co-founder, President & CEO of Combangio.  He is a Board member of Combangio and Kedalion Therapeutics.  Mr. Kharabi focuses on company creation at Lagunita and previously served as executive management for xCella and Kedalion, helping to build early value, raise financing and recruit full-time leadership teams.  Prior to Lagunita, he served as Vice President, Corporate Development and International Sales at OrthAlign Inc., a commercial stage orthopedic surgery navigation company, where his responsibilities included the launch of the KneeAlign® total knee arthroplasty navigation product line in North America, Europe, Asia and Australia.  Mr. Kharabi started his career as a biotechnology licensing attorney at Wilson, Sonsini Goodrich & Rosati PC.  He received his B.S. in Biochemistry from Georgetown University and his J.D. and M.B.A. degrees from Stanford University

​